TipRanks
Modern Chinese Medicine Group Co. Ltd. (HK:1643)
:1643
Hong Kong Market
1643
Modern Chinese Medicine Group Co. Ltd.
RESEARCH TOOLSreports
Want to see HK:1643 full AI Analyst Report?

Modern Chinese Medicine Group Co. Ltd. (1643) Ratios

0 Followers

Modern Chinese Medicine Group Co. Ltd. Ratios

HK:1643's free cash flow for Q2 2026 was ¥0.17. For the 2026 fiscal year, HK:1643's free cash flow was decreased by ¥ and operating cash flow was ¥-0.17. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 9.12 8.54 7.20 8.93 5.49
Quick Ratio
 7.55 7.79 6.58 7.98 4.92
Cash Ratio
 4.79 5.92 4.69 5.86 3.85
Solvency Ratio
 -0.88 -0.04 0.28 0.99 1.19
Operating Cash Flow Ratio
 -4.21 0.13 1.20 0.17 1.71
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
¥ 197.16M¥ 285.80M¥ 296.42M¥ 380.87M¥ 323.89M
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.07 1.09 1.12 1.12 1.19
Debt Service Coverage Ratio
 -292.92 -714.59 24.68K 11.05K 6.68K
Interest Coverage Ratio
 -671.03 -2.73K 22.33K 13.37K 9.01K
Debt to Market Cap
 0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Net Debt to EBITDA
 5.00 49.64 -7.70 -3.83 -2.17
Profitability Margins
Gross Profit Margin
13.81%16.07%25.78%30.28%42.73%
EBIT Margin
-19.35%-11.30%11.13%19.85%31.11%
EBITDA Margin
-11.99%-3.27%13.93%21.73%32.54%
Operating Profit Margin
-19.35%-11.30%10.43%19.43%31.55%
Pretax Profit Margin
-24.62%-9.66%6.92%19.85%31.11%
Net Profit Margin
-21.07%-9.34%4.52%14.18%21.98%
Continuous Operations Profit Margin
-21.07%-9.34%4.52%14.18%21.98%
Net Income Per EBT
85.59%96.69%65.25%71.44%70.65%
EBT Per EBIT
127.27%85.50%66.37%102.15%98.60%
Return on Assets (ROA)
-8.35%-2.43%1.79%9.23%17.51%
Return on Equity (ROE)
-8.62%-2.65%2.00%10.32%20.77%
Return on Capital Employed (ROCE)
-8.07%-3.16%4.54%13.94%29.45%
Return on Invested Capital (ROIC)
-6.89%-3.06%2.97%9.96%20.79%
Return on Tangible Assets
-8.55%-2.43%1.79%9.24%17.52%
Earnings Yield
-12.13%-4.37%4.58%26.40%30.14%
Efficiency Ratios
Receivables Turnover
 3.20 2.28 2.42 3.34 5.12
Payables Turnover
 8.95 3.91 4.88 7.67 5.83
Inventory Turnover
 4.35 4.10 5.20 5.16 5.51
Fixed Asset Turnover
 0.98 0.72 1.15 3.92 4.44
Asset Turnover
 0.40 0.26 0.40 0.65 0.80
Working Capital Turnover Ratio
 0.80 0.47 0.62 0.96 1.38
Cash Conversion Cycle
 157.37 155.62 146.21 132.46 74.90
Days of Sales Outstanding
 114.13 159.86 150.87 109.35 71.32
Days of Inventory Outstanding
 84.00 89.08 70.19 70.70 66.20
Days of Payables Outstanding
 40.76 93.32 74.84 47.59 62.61
Operating Cycle
 198.13 248.94 221.05 180.05 137.51
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.15 <0.01 0.10 0.01 0.21
Free Cash Flow Per Share
 -0.18 -0.03 -0.09 <0.01 0.19
CapEx Per Share
 0.03 0.03 0.19 <0.01 0.02
Free Cash Flow to Operating Cash Flow
 1.20 -3.42 -0.94 0.40 0.91
Dividend Paid and CapEx Coverage Ratio
 -5.00 0.23 0.52 1.66 6.28
Capital Expenditure Coverage Ratio
 -5.00 0.23 0.52 1.66 10.73
Operating Cash Flow Coverage Ratio
 -87.51 70.30 436.90 117.72 320.07
Operating Cash Flow to Sales Ratio
 -0.53 0.03 0.28 0.02 0.31
Free Cash Flow Yield
-36.69%-5.48%-26.18%1.83%39.14%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -7.92 -22.90 21.85 3.79 3.32
Price-to-Sales (P/S) Ratio
 1.74 2.14 0.99 0.54 0.73
Price-to-Book (P/B) Ratio
 0.73 0.61 0.44 0.39 0.69
Price-to-Free Cash Flow (P/FCF) Ratio
 -2.73 -18.24 -3.82 54.72 2.55
Price-to-Operating Cash Flow Ratio
 -3.27 62.31 3.58 21.81 2.32
Price-to-Earnings Growth (PEG) Ratio
 0.21 0.10 -0.27 -0.08 0.46
Enterprise Value Multiple
 -9.50 -15.70 -0.61 -1.36 0.07
Enterprise Value
 225.19M 72.67M -18.20M -101.35M 9.53M
EV to EBITDA
 -9.50 -15.70 -0.61 -1.36 0.07
EV to Sales
 1.14 0.51 -0.09 -0.29 0.02
EV to Free Cash Flow
 -1.79 -4.38 0.33 -30.00 0.08
EV to Operating Cash Flow
 -2.14 14.97 -0.31 -11.96 0.08
Tangible Book Value Per Share
 0.63 0.75 0.81 0.79 0.70
Shareholders’ Equity Per Share
 0.65 0.75 0.81 0.79 0.70
Tax and Other Ratios
Effective Tax Rate
 0.14 0.03 0.35 0.29 0.29
Revenue Per Share
 0.27 0.21 0.36 0.57 0.67
Net Income Per Share
 -0.06 -0.02 0.02 0.08 0.15
Tax Burden
 0.86 0.97 0.65 0.71 0.71
Interest Burden
 1.27 0.85 0.62 1.00 1.00
Research & Development to Revenue
 0.00 0.00 <0.01 <0.01 <0.01
SG&A to Revenue
 0.33 0.28 0.15 0.03 0.04
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 2.52 -0.37 3.98 0.17 1.01
Currency in CNY